Suzanne Mitchell, Author at Born2Invest

Suzanne Mitchell

Suzanne Mitchell juggles the busy life of a full-time mom and entrepreneur while also being a writer-at-large for several business publications. Her work mostly covers the financial sector, including traditional and alternative investing. She shares reports and analyses on the real estate, fintech and cryptocurrency markets. She also likes to write about the health and biotech industry, in particular its intersection with clean water and cannabis. It is one of her goals to always share things of interest to women who want to make their mark in the world.

Born2Invest uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Born2Invest

Suzanne Mitchell

Stories By Suzanne Mitchell

How ETFs could support the biotech ecosystem

Making Genetics seeks €3 million to conduct a clinical trial in Europe

Noventure grows in healing technology with new acquisitions

RheoDx is looking for one million euros to accelerate blood diagnostics

Rovi will also produce Moderna’s COVID-19 vaccine in Andalusia

Mediquo closes 2.3 million round with business angel Carlos Blanco and Dozen

Boehringer Ingelheim increases revenues by 3% in 2020 to €19.57 billion

Marsi Bionics closes €1 million round through Fellow Funders

Inbrain Neuroelectronics closes €14.3 million round led by Asabys and Alta

Sapio Life focuses its expansion in Spain with new services and opens up to acquisitions